Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity (Q33658626)
scientific article
Language:
(P31) (Q13442814)
(P304) 495-499
(P407) (Q1860)
(P433) 3
(P478) 102
(P577) Tuesday, January 5, 2010
(P921) (Q413299)
(P1433) (Q326309)
(P1476) "Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity" (language: en)
(P2093) J-M Lee
G A Sarosy
C M Annunziata
N Azad
L Minasian
H Kotz
J Squires
N Houston
E C Kohn
(P2860) (Q37463883)
(Q36848153)
(Q33380559)
(Q27861075)
(Q46733389)
(Q29614302)
(Q28258045)
(Q36969009)
(Q28282767)
(Q28278736)
(Q36149950)
(Q27861059)
(Q29618610)
(Q34483845)
(Q29547900)
(Q27860904)
(Q46892024)
(Q46735182)
(Q46502913)
other details